April 27, 2015
GOG-9928Closed to patient entry effective April 27, 2015. Accrual goal has been met.

RTOG-0926:  Amendment 3 (version date:  March 6, 2015) and Amendment 4 (version date:  April 20, 2015)

GOG-0265: Amendments 10 – 11. Version date: April 22, 2015

GOG-0275: Amendment 5. Version date: March 25, 2015

NRG-HN001: Amendment 1 (version date: October 9, 2014) and Amendment 2 (version date: March 4, 2015)

NRG-HN001: The Blank Rave form has been revised and is available at https://www.ctsu.org/public/. Use the revised version date April 22, 2015 immediately.

GOG-0274 / RTOG 1174: OUTBACK Trial - Open Query Report Memo

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, 0920 and NRG-HN001. Space is limited so register now and reserve your seat.  The next training is scheduled for May 26, 2015.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members' Area or the E-mail Distributions page and the CTSU website.

Safety updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page.

New Clinical Trial
Please be advised of a new clinical trial sponsored by Novartis, A randomized, blinded, placebo-controlled phase II trial of LEE011 in patients with relapsed, refractory, incurable teratoma. (NCT02300987). Eligible patients include men and women with Growing Teratoma Syndrome.  Read More

The SOCRA exam will be available at the NRG Oncology semiannual meeting in July. Please visit the SOCRA website for registration and further information.
Sheraton Denver Hotel Downtown
July 16, 2015 - 9:00 a.m. - 1:00 p.m.
Application Deadline: 6/4/2015
NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP. Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513.
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):961-7. doi: 10.1016/j.ijrobp.2014.12.050.
PubMed PMID: 25832688..  Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming scientific meetings
American Association of Neurological Surgeons (AANS), May 2-6, 2015, Washington, DC
American College of Radiology (ACR)  inaugural meeting, May 17–21, 2015, Washington DC
American Society of Breast Surgeons (ASBS), Apr 29 - May 3, 2015, Orlando, FL
American Urology Association (AUA), May 15-19, 2015, New Orleans, LA
Digestive Disease Week (DDW), May 16-19, 2015, Washington, DC
International Gynecologic Cancer Society (IGCS) – Regional Meeting, May 10-12, 2015, Santiago, Chile

Upcoming abstract submission deadlines
European Society for Medical Oncology (ESMO), Sep 25-29, 2015, Vienna, Austria, meeting submission deadline Apr 28, 2015

European Society of Gynaecolocial Oncology (ESGO) Oct 24-27, 2015, Nice, France, meeting submission deadline May 5, 2015

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103